drugset / Trial / NCT05068960

Postoperative Pain Control in Total Shoulder Arthroplasty

NCT05068960 ↗

Phase 4 Completed 100 enrolled Scripps Clinic
RandomizedParallel-groupQuadruple-blindTreatment

Summary

A double blind, prospective, randomized trial to evaluate postoperative pain, narcotic use, patient satisfaction, and function among shoulder arthroplasty patients receiving interscalene block with and without the addition of liposomal bupivacaine.

Timeline

Start
2021-03-01
Primary completion
2025-02-01
Completion
2025-02-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Bupivacaine Other / unclassified 10 ml Other
Subject Bupivacaine Other / unclassified 20 ml Other
Subject Bupivacaine Other / unclassified 133 mg Other

Indications

No indication recorded.